GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AP Biosciences Inc (ROCO:6945) » Definitions » Total Debt per Share

AP Biosciences (ROCO:6945) Total Debt per Share : NT$0.83 (As of Dec. 2024)


View and export this data going back to 2023. Start your Free Trial

What is AP Biosciences Total Debt per Share?

NT$0.83 (As of Dec. 2024)

Total Debt per Share is calculated as total debt divided by Shares Outstanding (EOP). Total debt is calculated as Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. AP Biosciences's Total Debt Per Share for the quarter that ended in Dec. 2024 was NT$0.83.


AP Biosciences Total Debt per Share Historical Data

The historical data trend for AP Biosciences's Total Debt per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AP Biosciences Total Debt per Share Chart

AP Biosciences Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
Total Debt per Share
- - - 1.27 0.83

AP Biosciences Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Total Debt per Share Get a 7-Day Free Trial - 1.32 1.27 0.90 0.83

AP Biosciences Total Debt per Share Calculation

AP Biosciences's Total Debt Per Share for the fiscal year that ended in Dec. 2024 is calculated as:

AP Biosciences's Total Debt Per Share for the quarter that ended in Dec. 2024 is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


AP Biosciences Total Debt per Share Related Terms

Thank you for viewing the detailed overview of AP Biosciences's Total Debt per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


AP Biosciences Business Description

Traded in Other Exchanges
N/A
Address
No. 3, Park Street, 17th Floor, Taipei, TWN
AP Biosciences Inc is a clinical-stage bispecific antibody new drug research and development company. It has developed a series of antibody and protein lead drugs through a self-designed technology platform for unmet medical needs, focusing on Specific targets associated with diseases to deliver safe, effective and cost-effective medicines.

AP Biosciences Headlines

No Headlines